Terrapinn's world influenza congress Europe 2009. Part 2
- PMID: 20127556
Terrapinn's world influenza congress Europe 2009. Part 2
Abstract
Terrapinn's World Influenza Congress Europe 2009, held in Brussels, included topics covering new developments in the field of influenza vaccination. This conference report highlights selected presentations on the use of novel technologies for developing vaccines for influenza. Investigational vaccines discussed include Multimeric-001 (BiondVax Pharmaceuticals Ltd), NB-1008 (NanoBio Corp) and an influenza vaccine containing the CAF-01 adjuvant (Statens Serum Institut).
MeSH terms
Substances
LinkOut - more resources
Medical